Loading live market data…

Lineage, Inc.

NASDAQ:LINE

$44.325 USD

$0.33 (0.74%)

Volume
645.39K
Average Volume
1.02M
Market Capitalization
$10.09B
P/E Ratio
-71.50
Dividend Yield
4.78%
Price Target
$45.00
Year High
$45.75
Year Low
$31.33
Day High
—
Day Low
—
Payout Ratio
$-3.67
Current Ratio
$0.85

Industry, Sector & symbol

Stock Exchange NASDAQ
CEO W. Gregory Lehmkuhl
Industry REIT - Industrial
Sector Real Estate
Current Symbol LINE
CUSIP 53566V106
CIK 0001868159
Web https://www.onelineage.com
Phone 800-678-7271
Currency USD
Employees 24000
Country US

Liquidity

Debt-to-Equity Ratio 1.01
Payout Ratio -3.67
Current Ratio 0.85
Quick Ratio 0.76
Cash Ratio 0.04

Sales & Book Value

Annual Sales $5.36B
Price / Sales 1.88
Cash Flow 0.67
Price / Cash Flow 65.96
Price / Book 1.24

Price Target and Rating

Average Stock Price Forecast $45.00
High Stock Price Forecast $47.00
Low Stock Price Forecast $35.00
Forecast Upside/Downside -1.50%
Consensus Rating Sell
Rating Score(0-5) 2
Research Coverage 16 Analysts

Profitability

EPS (Most Recent Fiscal Year) $-0.43
Trailing P/E Ratio -71.50
PEG Ratio -1.30
P/E Growth -1.30
Net Income $-98M
Net Margin -2.72%
Pretax Margin -3.17%
Return on Equity -1.75%
Return on Assets -0.77%

Financials Score

AltmanZ Score 0.75
Piotroski Score 3.00
Working Capital -227M
Total Assets 19.05B
Ebit 442M
Market Cap 10.02B
Total Liabilities 9.99B

Poll Results

About Lineage, Inc. (NASDAQ:LINE) Stock

Lineage, Inc. operates as a real estate investment trust (REIT) primarily focused on temperature-controlled warehouse properties. Its business activities are organized into two main divisions: Global Warehousing and Global Integrated Solutions. The Global Warehousing segment manages a portfolio of industrial real estate assets that provide refrigerated and frozen storage services to its customers. The Global Integrated Solutions segment, in contrast, specializes in delivering tailored cold-chain logistics services. This company was established in 2008 and has its corporate headquarters situated in Novi, Michigan. ...

Lineage Cell Therapeutics Maps COR1 Path With ‘Thaw and Inject' Cell Therapy Plan

2026-07-14 03:02:24

Lineage Cell Therapeutics NYSEAMERICAN: LCTX used a conference call to outline its manufacturing strategy and development plans for COR1, a wholly owned preclinical cell transplant program being developed as a potential treatment for corneal endothelial disease.

Lineage Provides Update on COR1 Cell Therapy Program for Corneal Endothelial Disease

2026-07-13 08:00:00

CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel, allogeneic, “off the shelf”, cell therapies for serious medical conditions, today provided an update on COR1, the Company's allogeneic corneal endothelial cell (CEnC) transplant program, in preclinical development for the treatment of corneal endothelial disease. With COR1, Lineage is deploying its ophthalmology and cell manufacturing expert.

Lineage: Don't Mistake A Cyclical Slump For A Broken Business

2026-07-09 07:01:55

Lineage remains a Buy, offering a margin of safety and re-rating potential despite near-term macro and operational headwinds. Q1 saw AFFO per share decline 9.3% to $0.78, but guidance for Adj. EBITDA ($1.25–$1.3B) and AFFO per share ($2.75–$3.00) were maintained. LINE's cost reduction plan and automation investments target $110M annualized EBITDA improvement in 3–5 years, supporting long-term upside.

Grand Design RV Unveils the All-New Lineage Series E, Redefining Innovation in Motorized RV Travel

2026-07-08 09:59:00

MIDDLEBURY, Ind., July 08, 2026 (GLOBE NEWSWIRE) -- Grand Design RV, the fast-growing innovator of travel trailers, 5th wheels and motorized RVs, today announced the launch of the all-new Lineage series E, expanding its award-winning motorized portfolio with a new Class C motorhome designed to deliver premium comfort, practical functionality and confidence on the road. Built on the dependable Ford® E-450 chassis, the Series E brings Grand Design's owner-focused approach to one of the most established and accessible segments of the motorized RV market.

Linear Provides Update on Proposed Acquisition of Critical Prospecting Corp

2026-07-07 21:25:00

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESS Newswire / July 7, 2026 / Linear Minerals Corp. (CSE:LINE)(OTCID:LINMF) (WKN:A40Y3E) ("Linear" or the "Company") is pleased to provide an update on its previously announced letter of intent (the "LOI") to acquire all of the issued and outstanding securities of Critical Prospecting Corp. initially announced in the Company's news release dated May 21, 2026. The Company confirms that it continues to work towards completing the proposed acquisition of certain mineral properties (the "Properties") from Critical Prospecting Corp. (the "Vendor").

Lineage to Report Second-Quarter 2026 Financial Results on August 5, 2026

2026-07-07 16:15:00

NOVI, Mich.--(BUSINESS WIRE)--Lineage, Inc. (NASDAQ: LINE), announced that it will report its financial results for the second quarter of 2026 on Wednesday, August 5, 2026, before market open. A conference call to discuss these results has been scheduled for 8:00 a.m. Eastern Time on Wednesday, August 5, 2026. A live webcast of the call will be available on the Lineage Investor Relations website at ir.onelineage.com. An audio replay of the conference call will be available for one week followin.

Lineage Cell Therapeutics to Present at B. Riley Securities 2026 Mind, Muscle & Vision Healthcare Summit

2026-07-06 08:00:00

CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing “off the shelf” allogeneic cell therapies for serious medical conditions, today announced that Brian M. Culley, Lineage's Chief Executive Officer, will be presenting at the B. Riley Securities 2026 Mind, Muscle & Vision Healthcare Summit, in a fireside chat hosted by Mayank Mamtani, Senior Managing Director, Group Head of Healthcare Research an.

Lineage vs. Rexford Industrial Realty: Which Real Estate Stock Is a Better Buy in 2026?

2026-06-26 07:17:01

Lineage operates a massive temperature-controlled logistics network across three continents. Rexford Industrial Realty maintains a high-density portfolio focused exclusively on Southern California.

Frequently Asked Questions

What is the current Lineage, Inc. (LINE) stock price?

Lineage, Inc.(NASDAQ:LINE) stock price is $44.325 in the last trading session. During the trading session, LINE stock reached the peak price of $45.75 while $31.33 was the lowest point it dropped to. The percentage change in LINE stock occurred in the recent session was 0.74% while the dollar amount for the price change in LINE stock was $0.33.

LINE's industry and sector of operation?

The NASDAQ listed LINE is part of REIT - Industrial industry that operates in the broader Real Estate sector.

Who are the executives of LINE?

Chris Johnson | Vice President of Technology Projects
Robb A. LeMasters | Chief Financial Officer
Timothy Smith | Chief Commercial Officer
Adam Forste | Co-Founder & Co-Executive Chairman
Kevin Patrick Marchetti | Co-Founder & Co-Executive Chairman

How many employees does LINE have?

Number of LINE employees currently stands at 24000. LINE operates from 46500 Humboldt Drive, Novi, MI 48377, US.

Link for LINE official website?

Official Website of LINE is: https://www.onelineage.com

How do I contact LINE?

LINE could be contacted at phone #800-678-7271 and can also be accessed through its website. LINE operates from 46500 Humboldt Drive, Novi, MI 48377, US.

How many shares of LINE are traded daily?

The average number of LINE shares traded daily for last 3 months was 1.02M.

What is the market cap of LINE currently?

The market value of LINE currently stands at $10.09B with its latest stock price at $44.325